-
1
-
-
0034685037
-
Antiretroviral therapy in adults: Updated recommendations of the International AIDS Society- USA Panel
-
Carpenter CC, Cooper DA, Fischl MA, Gatell JM, Gazzard BG, Hammer SM, Hirsch MS, Jacobsen DM, Katzenstein DA, Montaner IS, Richman DD, Saag MS, Schechter M, Schooley RT, Thompson MA, Vella S, Yeni PG & Volberding PA. Antiretroviral therapy in adults: updated recommendations of the International AIDS Society- USA Panel. Journal of the American Medical Association 2000; 283:381-390.
-
(2000)
Journal of the American Medical Association
, vol.283
, pp. 381-390
-
-
Carpenter, C.C.1
Cooper, D.A.2
Fischl, M.A.3
Gatell, J.M.4
Gazzard, B.G.5
Hammer, S.M.6
Hirsch, M.S.7
Jacobsen, D.M.8
Katzenstein, D.A.9
Montaner, I.S.10
Richman, D.D.11
Saag, M.S.12
Schechter, M.13
Schooley, R.T.14
Thompson, M.A.15
Vella, S.16
Yeni, P.G.17
Volberding, P.A.18
-
2
-
-
0033615280
-
Reduced antiretroviral drug susceptibility among patients with primary HIV infection
-
Little SJ, Daar ES, D'Aquila RT, Keiser PH, Connick E, Whitcomb JM, Hellmann NS, Petropoulos CJ, Sutton L, Pitt JA, Rosenberg ES, Koup RA, Walker BD & Richman DD. Reduced antiretroviral drug susceptibility among patients with primary HIV infection. Journal of the American Medical Association 1999; 282:1142-1149.
-
(1999)
Journal of the American Medical Association
, vol.282
, pp. 1142-1149
-
-
Little, S.J.1
Daar, E.S.2
D'Aquila, R.T.3
Keiser, P.H.4
Connick, E.5
Whitcomb, J.M.6
Hellmann, N.S.7
Petropoulos, C.J.8
Sutton, L.9
Pitt, J.A.10
Rosenberg, E.S.11
Koup, R.A.12
Walker, B.D.13
Richman, D.D.14
-
3
-
-
0002492160
-
Primary HIV infection: In vivo fitness of pre-therapy resistant mutants and potential for secondary spread of HIV from semen
-
DePasquale M, Rosenberg E, Quayle A, Tremblay C, Martinez-Picado J, Allegra J, Sutton L, Shi L, Savara A, Boswell S, Sax P, Hirsch, M., Caliendo A, Anderson D, Walker B & D'Aquila R. Primary HIV infection: In vivo fitness of pre-therapy resistant mutants and potential for secondary spread of HIV from semen. Antiviral Therapy 1999; 4 (Suppl. 1):89.
-
(1999)
Antiviral Therapy
, vol.4
, Issue.SUPPL. 1
, pp. 89
-
-
DePasquale, M.1
Rosenberg, E.2
Quayle, A.3
Tremblay, C.4
Martinez-Picado, J.5
Allegra, J.6
Sutton, L.7
Shi, L.8
Savara, A.9
Boswell, S.10
Sax, P.11
Hirsch, M.12
Caliendo, A.13
Anderson, D.14
Walker, B.15
D'Aquila, R.16
-
4
-
-
0034019566
-
A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1
-
Petropoulos C, Parkin N, Limoli K, Lie Y, Wrin T, Huang W, Tian H, Smith D, Winslow G, Capon D & Whitcomb J. A novel phenotypic drug susceptibility assay for human immunodeficiency virus type 1. Antimicrobial Agents and Chemotherapy 2000; 44:920-928.
-
(2000)
Antimicrobial Agents and Chemotherapy
, vol.44
, pp. 920-928
-
-
Petropoulos, C.1
Parkin, N.2
Limoli, K.3
Lie, Y.4
Wrin, T.5
Huang, W.6
Tian, H.7
Smith, D.8
Winslow, G.9
Capon, D.10
Whitcomb, J.11
-
5
-
-
0000498539
-
Analysis of possible predictors of response to abacavir (ABC) in antiretroviral-experienced adults; comparison of viral genotype, viral phenotype and patient treatment history
-
February Chicago, USA, Abstract 134
-
th Conference on Retroviruses and Opportunistic Infections. February 1999, Chicago, USA, Abstract 134.
-
(1999)
th Conference on Retroviruses and Opportunistic Infections.
-
-
Lanier, R.1
Ait-Khaled, M.2
Madison, S.3
Hetherington, S.4
Wang, B.5
Dix, L.6
Lafon, S.7
|